Sign inGet started

Ondrey Aaron

Insider CIK 1991078 · RCKT Chief Financial Officer · MRTX Interim CFO

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RCKT ROCKET PHARMACEUTICALS, IN S Sale2025-07-032025-07-081,477$2.88 $4.3K128,173SEC↗
RCKT ROCKET PHARMACEUTICALS, IN S Sale2025-04-042025-04-087,489$5.29 $39.6K129,650SEC↗
RCKT ROCKET PHARMACEUTICALS, IN A Award deriv2025-02-112025-02-13134,642— $0134,642SEC↗
RCKT ROCKET PHARMACEUTICALS, IN A Award2025-02-112025-02-1390,358— $0137,139SEC↗
RCKT ROCKET PHARMACEUTICALS, IN A Award deriv2024-04-012024-04-0369,337— $069,337SEC↗
RCKT ROCKET PHARMACEUTICALS, IN A Award2024-04-012024-04-0346,781— $046,781SEC↗
MRTX Mirati Therapeutics, Inc. D To issuer deriv2024-01-232024-01-236,817— $00SEC↗
MRTX Mirati Therapeutics, Inc. D To issuer deriv2024-01-232024-01-235,027— $00SEC↗
MRTX Mirati Therapeutics, Inc. D To issuer deriv2024-01-232024-01-2311,993— $00SEC↗
MRTX Mirati Therapeutics, Inc. D To issuer2024-01-232024-01-2317,021— $00SEC↗
MRTX Mirati Therapeutics, Inc. D To issuer2024-01-232024-01-231,302— $038,159SEC↗
MRTX Mirati Therapeutics, Inc. D To issuer2024-01-232024-01-2321,138— $017,021SEC↗
MRTX Mirati Therapeutics, Inc. A Award2023-12-292024-01-0317,021$58.75 $1000.0K39,461SEC↗
MRTX Mirati Therapeutics, Inc. A Award2023-09-082023-09-128,412$35.66 $300.0K22,440SEC↗